EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES: AN OPEN-LABEL, PHASE-III, EXTENSION STUDY

被引：4
|
作者：
Brogan, P. A. [1 ,2 ]
Hofer, M. [3 ]
Kuemmerle-Deschner, J. B. [4 ]
Lauwerys, B. [5 ,6 ]
Speziale, A. [7 ]
Leon, K. [8 ]
Wei, X. [9 ]
Laxer, R. [10 ]
机构：
[1] UCL Inst Child Hlth, Dept Infect Inflammat & Rheumatol, London, England
[2] Great Ormond St Hosp NHS Fdn Trust, London, England
[3] Hosp Univ Vaudois, Unite Romande Rhumatol Pediat, Lausanne, Switzerland
[4] Univ Hosp Tuebingen, Tubingen, Germany
[5] Clin Univ St Luc, Brussels, Belgium
[6] Catholic Univ Louvain, Brussels, Belgium
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharmaceut, Beijing, Peoples R China
[10] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4865
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0503
引用
收藏
页码：620 / 621
页数：2
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF CANAKINUMAB IN A LARGE COHORT OF PATIENTS ACROSS DIFFERENT SEVERITY PHENOTYPES OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME (CAPS)
    Lachmann, H. J.
    Kuemmerle-Deschner, J. B.
    Hachulla, E.
    Kone-Paut, I
    Hoyer, J.
    Smith, J.
    Leslie, K.
    Patel, N.
    Preiss, R.
    Hawkins, P. N.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S93 - S93
  • [42] Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study
    Jaeger, Veronika K.
    Hoffman, Hal M.
    van der Poll, Tom
    Tilson, Hugh
    Seibert, Julia
    Speziale, Antonio
    Junge, Guido
    Franke, Kristina
    Vritzali, Eleni
    Hawkins, Philip N.
    Kuemmerle-Deschner, Jasmin
    Walker, Ulrich A.
    RHEUMATOLOGY, 2017, 56 (09) : 1484 - 1491
  • [43] An open-label extension study of lurasidone safety and efficacy in patients with schizophrenia previously randomized to lurasidone or risperidone
    Mattingly, G.
    Tocco, M.
    Cucchiaro, J.
    Xu, J.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 147 - 147
  • [44] An Open-Label Extension Study to Evaluate Safety and Efficacy of Pazopanib in Patients with Advanced Renal Cell Carcinoma
    Sternberg, Cora N.
    Davis, Ian D.
    Deen, Keith C.
    Sigal, Entisar
    Hawkins, Robert E.
    ONCOLOGY, 2014, 87 (06) : 342 - 350
  • [45] Safety and Efficacy of Belimumab in Patients with Lupus Nephritis Open-Label Extension of BLISS-LN Study
    Furie, Richard
    Rovin, Brad H.
    Houssiau, Frederic
    Contreras, Gabriel
    Teng, Y. K. Onno
    Curtis, Paula
    Green, Yulia
    Okily, Mohamed
    Madan, Anuradha
    Roth, David A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (11): : 1620 - 1630
  • [46] Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study
    Jang, Jun Ho
    Tomiyama, Yoshiaki
    Miyazaki, Koji
    Nagafuji, Koji
    Usuki, Kensuke
    Uoshima, Nobuhiko
    Fujisaki, Tomoaki
    Kosugi, Hiroshi
    Matsumura, Itaru
    Sasaki, Ko
    Kizaki, Masahiro
    Sawa, Masashi
    Hidaka, Michihiro
    Kobayashi, Naoki
    Ichikawa, Satoshi
    Yonemura, Yuji
    Enokitani, Kouki
    Matsuda, Akira
    Ozawa, Keiya
    Mitani, Kinuko
    Lee, Jong Wook
    Nakao, Shinji
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : 190 - 199
  • [47] Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
    B Bader-Meunier
    P Hachulla
    J Kuemmerle-Deschner
    M Gattorno
    N Patel
    R Preiss
    K Lheritier
    T Imagawa
    R Nishikomori
    H Takada
    T Heike
    T Hara
    S Yokota
    Pediatric Rheumatology, 9 (Suppl 1)
  • [48] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
    Xenofon Baraliakos
    Désirée van der Heijde
    Joachim Sieper
    Robert D. Inman
    Hideto Kameda
    Yihan Li
    Xianwei Bu
    Anna Shmagel
    Peter Wung
    In-Ho Song
    Atul Deodhar
    Arthritis Research & Therapy, 25
  • [49] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
    Baraliakos, Xenofon
    van der Heijde, Desiree
    Sieper, Joachim
    Inman, Robert D.
    Kameda, Hideto
    Li, Yihan
    Bu, Xianwei
    Shmagel, Anna
    Wung, Peter
    Song, In-Ho
    Deodhar, Atul
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [50] Efficacy and Safety of Canakinumab in a Large Cohort of Cryopyrin-Associated Periodic Syndrome (CAPS) Patients across All Severity Phenotypes
    Cartwright, R.
    Smith, J.
    Hawkins, P.
    Kuemmerle-Deschner, J.
    Hachulla, E.
    Kone-Paut, I.
    Hoyer, J.
    Quartier, P.
    Gattorno, M.
    Widmer, A.
    Patel, N.
    Preiss, R.
    Leslie, K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB226 - AB226
12345